Lundbeck
HLUN-B.CO
#2596
Rank
$6.62 B
Marketcap
$6.98
Share price
0.63%
Change (1 day)
14.82%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): $0.61

According to Lundbeck's latest financial reports the company's current EPS (TTM) is $0.61. In 2024 the company made an earnings per share (EPS) of $0.44 an increase over its 2023 EPS that were of $0.34.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$0.6138.48%
2024$0.4429.29%
2023$0.3423.09%
2022$0.2837.26%
2021$0.20-84.61%
2020$1.32-24.61%
2019$1.75-42.06%
2018$3.0140.7%
2017$2.14146.26%
2016$0.87-120.48%
2015-$4.243231.32%
2014-$0.13-115.78%
2013$0.81-23.36%
2012$1.05-48.01%
2011$2.03-9.68%
2010$2.2413.72%
2009$1.9724.32%
2008$1.59-6.05%
2007$1.6981.77%
2006$0.93-16.76%
2005$1.12-17.58%
2004$1.35